Clinical trials
Observational Atrial Fibrillation trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
301 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 11 |
| 2014 | 17 |
| 2015 | 10 |
| 2016 | 21 |
| 2017 | 17 |
| 2018 | 26 |
| 2019 | 23 |
| 2020 | 32 |
| 2021 | 38 |
| 2022 | 29 |
| 2023 | 27 |
| 2024 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 301 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charles University, Czech Republic | 6 |
| University Hospital, Caen | 6 |
| Yonsei University | 6 |
| Assiut University | 5 |
| Brigham and Women's Hospital | 4 |
| Medical University of Warsaw | 4 |
| Shanghai 10th People's Hospital | 4 |
| University College, London | 4 |
| Beijing Anzhen Hospital | 3 |
| Catharina Ziekenhuis Eindhoven | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 301 |
| Stroke | 40 |
| Ischemic Stroke | 16 |
| Arrhythmias, Cardiac | 15 |
| Heart Failure | 14 |
| Heart Diseases | 9 |
| Cardiovascular Diseases | 8 |
| Coronary Artery Disease | 8 |
| Hypertension | 8 |
| Ischemic Attack, Transient | 8 |
Trials
Showing 1 to 25 of 301. Each trial links to its page on Pharma Observatory.
201 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.